Sonja Kappel-Latif

1PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 19, 2018
• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

Sonja Kappel-Latif, Johannes Zacherl, Michael Hejna

Pageof 1

Frequent Collaborators